About Gelato #33

Cured properly, flowers of Gelato have a predominant smell of pungent citrus, compliments of fruity parent strain Sunset Sherbert.

Bred by Sherbinskis

Gelato is a hybrid crossed from taste-engineered parents Thin Mint Girl Scout Cookies and fruity indica Sunset Sherbert. With a balanced, mellow high and a universally appealing flavor profile, this is a great strain for social use. San Francisco creators Cookie Fam Genetics have released multiple numbered phenotypes of Gelato - phenotype #33 has picked up the nickname Larry Bird in reference to the legendary player’s jersey number. This strain has an indica-leaning high and carries a THC composition that ranges from 20% to 25%.

Gelato’s buds tend to be small but they have the thick and dense structure characteristic of many indica varieties. This is a strain with immediate visual appeal: bright orange pistils stand out against forest green leaves that are accented by shades of deep purple. The purple hues come about when high concentrations of pigments called anthocyanins are stimulated by cold weather in the vegetative stage. Although the buds themselves are sticky, short stalks on the trichomes mean that this strain has a less frosty appearance than many others. Cured properly, flowers of Gelato have a predominant smell of pungent citrus, compliments of fruity parent strain Sunset Sherbert. Notes of yeast and dough can be detected as well.

Grinding up or breaking apart the flowers gives off a more herbal, earthy profile.

Description provided by Wikileaf.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

About Grow Group PLC

At Grow, we know there are millions of patients who can benefit from cannabis medicines. We aim to cater to as many patients as possible by having the best basket of a variety of high-quality cannabis medicines.

GROW® is a Biopharmaceutical company created back in 2017, focused solely on cannabis-based medicines. Operating in both a vertically integrated and partner model to ensure the optimal, broadest supply of truly differentiated cannabis medicines to really drive the best outcomes for patients.

We put patients at the heart of everything we do.

growgroupplc.com